Great Ape Protection and Cost Savings Act of 2011

Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152 The Healthcare & Education Affordability Reconciliation Act of 2010--issues regarding CER, prescription importation, biosimilars, Physician Payment Sunshine implementation. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. "track and trace" issues. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Diabetes-related issues. S. 3463, Medicare Diabetes Prevention Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Prescription Drug User Fee Act reauthorization. Product exclusivity issues. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 3187, Food and Drug Administration Safety and Innovation Act. H.R. 6433, FDA User Fee Corrections Act of 2012. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. H.R. 5651, Food and Drug Administration Reform Act of 2012. S. 2516, Food and Drug Administration Safety and Innnovation Act. S. 3187, Food and Drug Administration Safety and Innovation Act. S. 2292, Patients' FDA Act. "Track and trace" legislation. H. J. Res. 117, Continuing Appropriations Resolution, 2013. H.R. 6433, FDA User Fee Corrections Act of 2012. H.R. 1513 / S. 810, Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Use of chimpanzees in biomedical research: "Great Ape Protection and Cost Savings Act of 2011" (S 810/ HR 1513)

Client expense: $70,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 3187, FDA Safety and Innovation Act; H.R. 4274, Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 1513/S. 810, Great Apes Protection Act; Pharmaceutical Traceability Enhancement Code (RxTEC) Act and draft legislation on downstream supply chain safety/serialization.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Food and Drug Administration Safety and Innovation Act Implementation Biosimilars Exclusivity Period in Administration's Budget Proposals Report on Innovation/FDA by President's Council of Advisors on Science and Technology (PCAST) H.R. 6433, FDA User Fee Corrections Act H.R. 1513, S. 810, Great Ape Protection & Cost Savings Act of 2011

Client expense: $370,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 1513, S 810 and related legislative proposals regarding the use of primates in clinical research

Client expense: $340,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 1406, Fairness to Pet Owners Act 2011 H.R. 1513, Great Ape Protection Act

Client expense: $1,730,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS)

S. 810; H.R. 1513, "Great Ape Protection and Cost Savings Act of 2011"

Client expense: $80,000 · Firm income: Not reported

Government targets: Education, Dept of, HOUSE OF REPRESENTATIVES, SENATE

HR 1513, S 810: Great Ape Protection and Cost Savings Act of 2011

Client expense: $30,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

H.R.1316, Stop Oxy Abuse Act of 2011: To limit the approval of any drug containing controlled-release oxycodone hydrochloride H.R. 1513, Great Ape Protection and Cost Savings Act of 2011: Provisions related to pre-clinical testing H.R. 2674, 340B Program Improvement Act: Provisions related to 340B H.R. 4132, FAST Act: Provisions related to accelerated approval and other FDA matters H.R. 4156, Expanding and Promoting Expertise in Rare Treatments Act of 2012: To strengthen the FDAs ability to seek advice from external experts regarding rare diseases H.R. 4209, Patients Access to Treatments Act: To limit cost-sharing requirements applicable to prescription drugs in a specialty drug tier H.R. 4274, To amend title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act of 2003 H.R. 6288, Patient Choice Act: To permit provisional approval of fast track products H.R. 6342, Compassionate Freedom of Choice Act: Provisions related to access to investigational drugs or devices for terminally ill patients H.R. 6584, Verifying Authority and Legality In Drug Compounding Act: Provisions relating to drug compounding H.R. 6611, Patient Access to Drugs in Shortage Act of 2012: Promote public notification and provide incentives to reduce drug shortages S. 296, Preserving Access to Life-Saving Medications Act: Provisions related to prescription drug shortages S. 810, Great Ape Protection and Cost Savings Act of 2011: Provisions related to pre-clinical testing S. 1699, Prescription Drug Cost Reduction Act: Provisions related to 340B S. 2002, Online Pharmacy Safety Act: To improve the safety of Internet pharmacies S. 2113, Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act: Provisions related to accelerated approval and other FDA matters S. 2236, Advancing Breakthrough Therapies for Patients Act of 2012: Provisions related to FDA regulation S.2281, Expanding and Promoting Expertise in Rare Treatments Act of 2012: To strengthen the FDAs ability to seek advice from external experts regarding rare diseases S. 3187, Food and Drug Administration Safety and Innovation Act: Provisions related to user fee reauthorization and FDA reform Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including PPACA; Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking Vaccine-related policy issues Comparative effectiveness policy issues General HHS and FDA related advocacy Biopharmaceutical innovation policy issues Pharmaceutical supply chain security issues

Client expense: $4,120,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Natl Security Council (NSC), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and draft legislation on downstream supply chain safety/serialization; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B; HR 1513 / S 810 Great Apes Protection Act

Client expense: $270,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE

Monitored and lobbied on issues relating to animal welfare (entire bills of the following): H.R.2492, the Animal Fighting Spectator Prohibition Act of 2011 H.R.3798 / S.3239, Egg Products Inspection Act Amendments of 2012 H.R.1513 / S.810, Great Ape Protection and Cost Savings Act S.1281, Horse Transportation Safety Act S.1324, the Captive Primate Safety Act H.R. 6388, To amend the Horse Protection Act to designate additional unlawful acts under the Act, strengthen penalties for violations of the Act, improve Department of Agriculture enforcement of the Act, and for other purposes.

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Advocated for establishing a uniform national approach to electronic tracking of prescription drugs for supply chain security. H.R. 1513 and S.810: Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1513 and S.810: Great Ape Protection and Cost Savings Act of 2011.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Animal Welfare Act Regulations & Policies H.R. 403 and H.R. 1417 - Battlefield Excellence through Superior Training Practices Act H.R. 1513 and S. 810 - Great Ape Protection and Cost Savings Act of 2011 H.R. 835 and S. 707 - Puppy Uniform Protection and Safety Act H. R. 6693 - To amend the Animal Welfare Act to provide for the protection of birds, rats, and mice, and for other purposes.

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

Great Ape Protection and Cost Savings Act of 2011: H.R.1513, S.810

Client expense: $44,974 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2146, S. 3600, Digital Accountability and Transparency Act of 2012, Issues pertaining to data collection for federal research funding. H.R. 4139, H.R. 4226, S. 1965, STARTUP Act, Issues pertaining to proof of concept grants for universities, technology transfer and STEM Visas. H.R. 3433, Grant Reform and New Transparency (GRANT) Act of 2011, Issues pertaining to grant applications and disclosure. H.R. 1513, S. 810, Great Ape Protection and Cost Savings Act of 2011, All provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 835 & S. 707, Puppy Uniform Protection and Safety Act, relating to commercial dog breeders H.R. 1513 & S. 810, Great Ape Protection and Cost Savings Act, relating to the use of chimps in research H.R. 2966 & S. 1176, American Horse Slaughter Prevention Act, to prohibit sale, transport, etc. of horses for slaughter for human consumption H.R. 2492 & S. 1947, Animal Fighting Spectator Prohibition Act, to prohibit attendance at animal fighting ventures S. 1281, Horse Transportation Safety Act, to prohibit transporting a horse in interstate commerce in a motor vehicle (except a vehicle operated exclusively on rail or rails) containing two or more levels stacked on top of one another H.R. 3798, Egg Products Inspection Act Amendments of 2012, would amend the Egg Products Inspection Act to revise housing and treatment of egg-laying hens and related enforcement provisions. H.R. 1733 & S. 886, Interstate Horseracing Improvement Act, would amend the Interstate Horseracing Act of 1978 to prohibit the use of performance-enhancing drugs in horseracing. H.R. 4103 & S. 2134, Canine Members of the Armed Services Act, relating to retiring military working dogs.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1513, S. 810, Great Ape Protection and Cost Savings Act of 2011, All provisions. H.R. 2146, S. 1222, S. 3600, Digital Accountability and Transparency Act of 2012, Issues pertaining to data collection and reporting requirements for federal research funding. H.R. 4139, H.R. 4226, S. 1965, STARTUP Act, Issues pertaining to proof of concept grants for universities, technology transfer and STEM Visas.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2146, S.1222, S.3600, Digital Accountability and Transparency Act (DATA), Issues pertaining to data collection for federal research funding. H.R. 1513, S. 810, Great Ape Protection and Cost Savings Act of 2011, All provisions.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1513, S. 810, Great Ape Protection and Cost Savings Act of 2011, All provisions.

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

H.R. 1513 and S.810 - Great Ape Protection and Cost Savings Act, provisions related to pre-clinical testing H.R. 1930 and S. 1799 - Access to Appropriate Immunizations for Veterans Act of 2011, provisions related to extending VA performance measure to include all federally recommended vaccine H.R. 2245, S. 296 - Preserving Access to Life-Savings Medicines Act of 2011, provisions related to drug shortages H.R. 2405 and S. 1855 - Pandemic and All Hazards Preparedness Act, provisions relating to influenza vaccine innovative technologies H.R. 2529 and S. 1368 - Restoring Access to Medication Act, provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 2674 - 340B Program Improvement Act, provisions related to the 340B program H.R. 4132 - FAST Act, provisions related to accelerated approval and other FDA matters H.R. 4156 amd S. 2281 - Expanding and Promoting Expertise in Rare Treatments Act of 2012, provisions related to strengthening the FDA's ability to seek advice from external experts regarding rare diseases H.R. 4223 and S. 1002 - Strengthening and Focusing Enforcement to Deter Organized Stealing and Enhance Safety Act (SAFE DOSES), provisions related to supply chain security H.R. 4274 - BPCA and PREA Reauthorization Act of 2012, Provisions related to amending title IV of the Public Health Service Act and title V of the Federal Food, Drug, and Cosmetic Act to permanently extend the provisions of the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act H.R. 5651 - Food and Drug Administration Reform Act of 2012, provisions related to user fee reauthorization and FDA reform H.R. 6190 - Asthma Inhalers Relief Act of 2012, provisions relating to the removal of Essential-Use Designation for epinephrine H.R. 6611 - Patients Access to Drugs in Shortage Act of 2012, provisions to promote public notification and provide incentives to reduce drug shortages S. 1584 - Drug Safety and Accountability Act of 2011, provisions related to drug safety S. 1699- Prescription Drug Cost Reduction Act, provisions related to 340B and drug rebates S. 1752 - Freedom to Breath Act of 2011, provisions relating to the removal of Essential-Use Designation for epinephrine S. 2113 - Transforming the Regulatory Environment to Accelerate Access to Treatments (TREAT) Act, provisions related to accelerated approval and other FDA matters S. 2236 - Advancing Breakthrough Therapies for Patients Act of 2012, provisions related to FDA regulation S. 2281 - Expanding and Promoting Expertise in Rare Treatments Act, provisions related to FDA regulation S. 2289 - The Better Pharmaceuticals and Devices for Children Act, provisions related to amending the Federal Food, Drug, and Cosmetic Act with respect to pediatric provisions S. 3187 - Food and Drug Administration Safety and Innovation Act of 2012, provisions related to user fee reauthorization and FDA reform PL 111-148, PL 111-152 - Patient Protection and Affordable Care Act, ACA implementation, Independent Payment Advisory Board (IPAB), comparative effectiveness, health information technology, disease prevention/wellness, sunshine and innovation provisions Federal Food, Drug, and Cosmetic Act, section related to FDA and regulation of nicotine replacement therapies Comparative effectiveness policy issues H.R. 6687, To amend the Internal Revenue Code of 1986 to include vaccines against seasonal influenza within the definition of taxable vaccines

Client expense: $1,370,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR), White House Office

H.R. 2146, S.1222, S.3600, Digital Accountability and Transparency Act (DATA) of 2012, Issues pertaining to data collection and reporting requirements for federal research funding. H.R. 3433, Grant Reform and New Transparency (GRANT) Act of 2011, Issues pertaining to transparency, intellectual property, and peer-review of federal grants. H.R. 1513, S. 810, Great Ape Protection and Cost Savings Act of 2011, All provisions. H.R. 3479, S. 646, The Natural Hazards Risk Reduction Act of 2011, Issues pertaining to research and the National Earthquake Hazards Reduction Program (NEHRP). H.R. 4139, H.R. 4226, S. 1965, STARTUP Act, Issues pertaining to proof of concept grants for universities, technology transfer and STEM Visas.

Client expense: Not reported · Firm income: $50,000

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, Natl Aeronautics & Space Administration (NASA), SENATE

H.R. 1513/S. 810, The Great Ape Protection and Cost Savings Act of 2011: opposition to provisions that restrict research on certain non-human primates

Client expense: $120,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), SENATE

H.R. 1513/S. 810, The Great Ape Protection and Cost Savings Act of 2011: opposition to provisions that restrict research on certain non-human primates

Client expense: $120,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), Defense, Dept of (DOD), Education, Dept of, HOUSE OF REPRESENTATIVES, Natl Oceanic & Atmospheric Administration (NOAA), Natl Science Foundation (NSF), Office of Management & Budget (OMB), SENATE

S. 1947/H.R. 2492 Animal Fighting Spectator Prohibition Act S. 810/H.R. 1513 Great Ape Protection and Cost Saving Act H.R. 3798/S.3239 Egg Products Inspection Act Amendments of 2012

Client expense: $140,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE

Drug safety and drug counterfeiting; Rebates for Medicare Part D; animal health; Federal preemption for prescription drugs; drug importation; and drug shortages. H.R. 1513; S. 810

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S. 810; H.R. 1513: "Great Ape Protection and Cost Savings Act of 2011," Section 3: "Definition of Great Ape;" Section 4: "Prohibitions," meaning of invasive research

Client expense: $40,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3699 Research Works Act - restricting public access to scientific articles arising from federally funded research. S. 2096 Federal Research Public Access Act requiring federal agencies to provide free public access to articles reporting on research they have funded. H.R. 4004 - Research Public Access Act requiring federal agencies to provide free public access to articles reporting on research they have funded. H.R. 2146 DATA Act, the Digital Accountability and Transparency Act, additional reporting requirements for federally funded research. S. 3600 - DATA Act, the Digital Accountability and Transparency Act, additional reporting requirements for federally funded research. HR 3433 GRANT Act, requiring agencies to post grant applications on-line H.R. 1513-Great Ape Protection and Cost Saving Act, bans all research using chimpanzees S. 810-Great Ape Protection and Cost Saving Act, bans all research using chimpanzees Farm Bill Reauthorization

Client expense: $70,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

S 810 and HR 1513 "Great Ape Protection and Cost Savings Act of 2011" - all provisions.

Client expense: Not reported · Firm income: $40,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Great Ape Protection and Cost Savings Act (S. 810, H.R. 1513), provisions relating to the use of animals in biomedical research.

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Presidents Budget, 2013, Department of Health and Human Services Unnumbered House subcommittee bill/S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, Title II Issues: Support funding for National Institutes of Health (NIH), human embryonic stem cell research, and Agency for Healthcare Research and Quality (AHRQ). Restore NIH salary cap to Executive Level I. Oppose AHRQ elimination and research policy provisions in the House subcommittee. Presidents Budget, 2013, Department of Veterans Affairs H.R. 5854/S. 3215, Military Construction-Veterans Affairs Appropriations Act, 2013, Title II Issues: Support funding for Veterans Affairs medical research and research infrastructure. Presidents Budget, 2014, National Science Foundation. H.R. 5326/S. 2323, Commerce, Justice, Science and Related Agencies Appropriations Act, 2013, Title III Issues: Support funding for the National Science Foundation and NSF's peer review process. H.R. 3433, Grant Reform and New Transparency (GRANT) Act of 2011 Issue: Support changes to the bill to protect intellectual property and the peer-review system. H.R. 733/S. 3560/S. 3566, Recalcitrant Cancer Research Act of 2012 Issue: Support National Institutes of Health peer review and strategic planning processes. Issue: Oppose nondefense discretionary spending cuts through sequestration, including NIH H.R. 1513/S. 810, Great Ape Protection and Cost Savings Act of 2011 H.R. 6672/H.R. 2405/S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act Issue: Complete reauthorization of preparednesss legistaion. Submitted comments on: Examination Guidelines on First Inventor to File Provisions AHRQ's Consumer Reporting System for Patient Safety Events Enhancing Community-Engaged Research Through the Clinical and Translational Science Awards Program

Client expense: $960,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Presidents Budget, 2013, Department of Health and Human Services Unnumbered House subcommittee bill/S.3295 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, Title II Issues: Support funding for National Institutes of Health (NIH), human embryonic stem cell research, Health Resources and Services Administration (HRSA), Title VII and Title VIII health professions and nursing education programs, National Health Service Corps, Childrens Hospitals graduate medical education (GME), Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control and Prevention (CDC), and CDCs National Center for Health Statistics. Restore NIH salary cap to Executive Level I. Oppose elimination of AHRQ, and research policy provisions in House subcommittee bill H.R. 6400, RDOCS Act of 2012 Issue: Support additional scholarship opportunities for medical students. President's Budget, 2013, Department of Health and Human Services Issues: Oppose proposed reduction in Medicare Graduate Medical Education (GME) support and proposed Medicaid reductions and reforms. Presidents Budget, 2014, Department of Veterans Affairs H.R. 5854/S. 3215, Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2013, Title II Issues: Support funding for Veterans Affairs medical research, research infrastructure, and health care. P.L. 111-148, Patient Protection and Affordable Care Act, Section 4002 and Title V Issue: Support the Prevention and Public Health Fund and preserve PPHF funds for workforce training. P.L. 111-148, Patient Protection and Affordable Care Act, Title V and Section 10503 Issue: Funding for Community Health Centers and the National Health Service Corps. Debt in Health Education Loan programs (Dbt HELP) bill proposal (draft) Issue: Expand National Health Service Corps State Loan Repayment program, align Department of Education and Health Resources and Services Administration student loan programs. S. 1627, Resident Physician Shortage Reducation Act Issue: Support lifting the cap on the number of residents Medicare will count when determining teaching hospitals' Medicare Direct Graduate Medical Education and Indirect Medical Education payments. P.L. 111-148, Patient Protection and Affordable Care Act, Title V Issue: Implementing provisions reauthorizing health professions education programs under Title VII of the Public Health Service Act, and reauthorizing National Health Service Corps. S. 3201 Graduate Medical Education Reform Act of 2012 Issue: Increase Medicare Graduate Medical Education (GME) accountability H.R. 3667, Primary Care Workforce Access Improvement Act Issue: Residency training in community-based settings. P.L. 111-148, Affordable Care Act Section 5503 and 5506 Issue: Redistribution of residency positions Issue: Implementation of Teaching Health Center Graduate Medical Education programs under section 340G of the Public Health Service Act. H.R. 1852/S. 958, Children's Hospital GME Support Reauthorization Act of 2011 S. 1440, The Prematurity Research Expansion and Education for Mothers who Deliver Infants Early Act. Issue: Support reauthorization of Children's Hospitals Graduate Medical Education. H.R. 1855/H.R. 2405, Pandemic and All-Hazards Preparedness Reauthorization Act. Issue: Complete reauthorization of preparedness legislation Act. H.R. 5707, Medicare Physician Payment Innovation Act Issue: Repeal of Medicare's sustainable growth rate (SGR) formula. H.R. 1513/S. 810, Great Ape Protection and Cost Saving Act of 2011 H.R. 6352, Resident Physician Shortage Reduction and Graduate Medical Education Accountability and Transparency Act Issue: Support lifting cap on number of residents Medicare will count when determining teaching hospitals' Medicare DGME and IME payments and increase GME accountability and transparency. H.R. 6562, Resident Physician Reduction Shortage Act of 2012 Issue: Support lifting cap on the number of residents Medicare will count when determining teaching hospitals' Medicare DGME and IME payments. Issue: Promote interprofessional education and training of the health care workforce. S. 799, Commercial Privacy Bill of Rights Act of 2011 Issue: Collection, retention, and dissemination of personal health information. Issue: Discuss with Administration impact of Medicaid expansions and Medicaid DSH cuts under the Affordable Care Act on AAMC member institutions. Issue: Funding for the National Healthcare Workforce Commission. H.R. 2954/S. 2474, Health Equity and Accountability Act of 2011 Issue: Developing health care workforce that promotes health equity. Issue: Health Insurance Exchanges mandated by the Affordable Care Act (ACA) to recognize and not penalize the unique missions of medical schools and teaching hospitals. Issue: Institute of Medicine (IOM) study on Graduate Medical Education (GME) financing and policies Issue: Support Medicare physician payment reform Issue: Oppose reduction in Medicare hospital outpatient department reimbursement Issue: Clarify policy changes on how to count Labor and Delivery beds when calculating Medicare GME payments. Issue: Oppose Medicare Graduate Medical Education (GME) spending cuts through sequestration. Issue: 340b Drug Discount program eligibility Issue: Oppose nondefense discretionary spending cuts through sequestration, including NIH and Title VII and VIII health professions and nursing education programs. Issue: Preventing, Identifying, and Treating Prescription Drug Abuse Issue: Primary Care Workforce Development Issue: Funding for Title VII and VIII in President's FY 2014 Budget Issue: Implementation of ACA Exchanges and Medicaid Expansions. Submitted comments on: AHRQ's Consumer Reporting System for Patient Safety Events Enhancing Community-Engaged Research Through the Clinical and Translational Science Awards Program

Client expense: $960,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

H.R. 1513/S. 810, Great Ape Protection and Cost Savings Act of 2011

Client expense: $960,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Presidents Budget, 2013, Department of Health and Human Services Unnumbered House subcommittee bill/S. 3295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2013, Title II Issues: Support funding for National Institutes of Health (NIH), human embryonic stem cell research, and Agency for Healthcare Research and Quality (AHRQ). Restore NIH salary cap to Executive Level I. Oppose AHRQ elimination and research policy provisions in House subcommittee bill Presidents Budget, 2014, Department of Veterans Affairs H.R. 5854/S. 3215, Military Construction-Veterans Affairs Appropriations Act, 2013, Title II Issues: Support funding for Veterans Affairs medical research and research infrastructure. H.R. 3433, Grant Reform and New Transparency (GRANT) Act of 2011 Issue: Support changes to the bill to protect intellectual property and the peer-review system. H.R. 733/S. 3560/S. 3566, Recalcitrant Cancer Research Act of 2012 Issue: Support National Institutes of Health peer review and strategic planning processes. H.R. 1513/S. 810: Great Ape Protection and Cost Savings Act of 2011 H.R. 6672/H.R. 2405/S. 1855, Pandemic and All-Hazards Preparedness Reauthorization Act Issue: Complete reauthorization of preparedness legislation. Submitted comments on: AHRQ's Consumer Reporting System for Patient Safety Events Enhancing Community-Engaged Research Through the Clinical and Translational Science Awards Program

Client expense: $960,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Great Ape Protection and Cost Saving Act of 2011 (S. 810/H.R. 1513)

Client expense: Not reported · Firm income: $30,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

S810 and HR1513 "Great Ape Protection and Cost Saving Act of 2011" - all provisions.

Client expense: $1,590,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Animal Welfare Act Regulations & Policies. HR 403 and HR 1417- Battlefield Excellence through Superior Training Practices Act. HR 1513 and S. 810 - Great Ape Protection and Cost Savings Act of 2011. HR 835 and S. 707 - Puppy Uniform Protection and Safety Act. HR 6693 - To Amend the Animal Welfare Act to provide for the protection of rats, mice and birds.

Client expense: Not reported · Firm income: $20,000

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE

HR 1513, S 810: Great Ape Protection and Cost Savings Act of 2011

Client expense: $30,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 2182, S1734, and S2187 (as passed in Pub. L. No. 112-144) issues related to the development of antibiotics H.R. 3026, S. 1882 and related legislative proposals regarding establishment/implementation of pharmaceutical pedigrees and tracking/tracing of pharmaceuticals from manufacturer to consumer HR 1483 - issues related to drug safety, supply chain, and facility inspections H.R. 2245, S.296, H.R. 3839 (Prescribing Access to Lifesaving Medications Act of 2011) and related legislative proposals regarding issues surrounding potential drug shortages, including notifications and public reporting H.R. 3668 issues related to increased penalties for counterfeiting drugs HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to 340B program amendments and implementation of statutory changes. HR 3590, S 1790 (as enacted into PL 111-148 and PL 111-152) issues related to definition of essential health benefits and health insurance exchanges. HR 6160 - issues related to drug safety issues, including tamper resistent packaging HR 1513 - issues related to animal research HR 6502 - issues related to development of medicines for life-threatening illnesses HR 3497 - issues related to incentives for developing and improving diagnostic tests and related treatments HR 6272 - issues related to the expansion of clinical trial data banks and increase government reporting of same HR 6163 - issues related to incentives for increased research into pediatric treatments

Client expense: $980,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 1513/S. 810, Great Ape Protection and Cost Savings Act of 2011

Client expense: $450,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Education, Dept of, Federal Reserve System, HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Interior, Dept of (DOI), Natl Institutes of Health (NIH), Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA), Veterans Affairs, Dept of (VA), White House Office

Animal Welfare Act Regulations & Policies H.R. 403 and H.R. 1417 - Battlefield Excellence through Superior Training Practices Act H.R. 1513 and S. 810 - Great Ape Protection and Cost Savings Act of 2011 H.R. 835 and S. 707 - Puppy Uniform Protection and Safety Act

Client expense: $20,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE